Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study
R Brauer, B Alfageh, JE Blais, EW Chan… - The Lancet …, 2021 - thelancet.com
Summary Background The WHO Comprehensive Mental Health Action Plan 2013–2030
encourages routine collection and reporting of a set of essential mental health indicators …
encourages routine collection and reporting of a set of essential mental health indicators …
Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis
Background Population-representative prevalence data for mental, neurological, and
substance use disorders are essential for evidence-based decision making. As a …
substance use disorders are essential for evidence-based decision making. As a …
International trends in antipsychotic use: a study in 16 countries, 2005–2014
The objective of this study was to assess international trends in antipsychotic use, using a
standardised methodology. A repeated cross-sectional design was applied to data extracts …
standardised methodology. A repeated cross-sectional design was applied to data extracts …
The increasing global health priority of substance use in young people
Substance use in young people (aged 10–24 years) might disrupt key periods of transition
that occur as the adolescent brain undergoes cognitive and emotional development, and …
that occur as the adolescent brain undergoes cognitive and emotional development, and …
New psychoactive substances: challenges for drug surveillance, control, and public health responses
The rapid emergence since the mid-2000s of a large and diverse range of substances
originally designed as legal alternatives to more established illicit drugs (pragmatically …
originally designed as legal alternatives to more established illicit drugs (pragmatically …
Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure
Objective: To examine changes in annual patterns of psychotropic medication use in
Australia from 2007 to 2015. Methods: We used a 10% sample of individual-level nationwide …
Australia from 2007 to 2015. Methods: We used a 10% sample of individual-level nationwide …
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
CP Stephenson, E Karanges… - Australian & New …, 2013 - journals.sagepub.com
Objective: This study examined longitudinal trends in the dispensing of psychotropic
medications in Australia from January 2000 to December 2011. Method: Dispensing data for …
medications in Australia from January 2000 to December 2011. Method: Dispensing data for …
Prevalence of mental disorders in China: a cross-sectional epidemiological study
Y Huang, YU Wang, H Wang, Z Liu, X Yu, J Yan… - The Lancet …, 2019 - thelancet.com
Summary Background The China Mental Health Survey was set up in 2012 to do a
nationally representative survey with consistent methodology to investigate the prevalence …
nationally representative survey with consistent methodology to investigate the prevalence …
Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010
S Ilyas, J Moncrieff - The British Journal of Psychiatry, 2012 - cambridge.org
BackgroundIncreasing rates of prescriptions for antidepressants, antipsychotics and
stimulants have been reported from various countries. AimsTo examine trends in …
stimulants have been reported from various countries. AimsTo examine trends in …
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
PS Wang, S Aguilar-Gaxiola, J Alonso… - The Lancet, 2007 - thelancet.com
Background Mental disorders are major causes of disability worldwide, including in the low-
income and middle-income countries least able to bear such burdens. We describe mental …
income and middle-income countries least able to bear such burdens. We describe mental …